Cellular cholesterol efflux mediated by cyclodextrins - PubMed (original) (raw)
. 1995 Jul 21;270(29):17250-6.
doi: 10.1074/jbc.270.29.17250.
Affiliations
- PMID: 7615524
- DOI: 10.1074/jbc.270.29.17250
Free article
Cellular cholesterol efflux mediated by cyclodextrins
E P Kilsdonk et al. J Biol Chem. 1995.
Free article
Abstract
In this study, we compared cholesterol efflux mediated by either high density lipoproteins (HDL3) or beta-cyclodextrins, cyclic oligosaccharides that are able to dissolve lipids in their hydrophobic core. beta-Cyclodextrin, 2-hydroxypropyl-beta-cyclodextrin, and methyl-beta-cyclodextrin at 10 mM induced the release of 50-90% of L-cell [3H]cholesterol after 8 h of incubation, with a major portion of this cholesterol being released in the first 1-2 h of incubation. The cholesterol efflux kinetics are different if cells are incubated with HDL3, which induces a relatively constant rate of release of cholesterol throughout an 8-h incubation. Cholesterol efflux to cyclodextrins was much greater than phospholipid release. To test the hypothesis that maximal efflux rate constants for a particular cell are independent of the type of acceptor, we estimated the maximal rate constants for efflux (Vmax) of cellular cholesterol from L-cells, Fu5AH cells, and GM3468A fibroblasts. The rate constant for HDL3-mediated efflux varied among cell lines in the order Fu5AH > L-cells > fibroblasts. However, these differences were not evident when cyclodextrins were used as cholesterol acceptors. The estimated Vmax values for cyclodextrin-mediated efflux were 3.5-70-fold greater than for HDL3 for the three cell lines. The very high efficiency of cyclodextrins in stimulating cell cholesterol efflux suggests that these compounds can be used in two general ways for studies of atherosclerosis: 1) as research tools to probe mechanisms of cholesterol transport and aspects of membrane structure or 2) as potential pharmacological agents that could modify in vivo cholesterol metabolism and influence the development of the atherosclerotic plaque.
Similar articles
- Cellular cholesterol efflux mediated by cyclodextrins. Demonstration Of kinetic pools and mechanism of efflux.
Yancey PG, Rodrigueza WV, Kilsdonk EP, Stoudt GW, Johnson WJ, Phillips MC, Rothblat GH. Yancey PG, et al. J Biol Chem. 1996 Jul 5;271(27):16026-34. doi: 10.1074/jbc.271.27.16026. J Biol Chem. 1996. PMID: 8663188 - Hydroxypropyl-beta-cyclodextrin-mediated efflux of 7-ketocholesterol from macrophage foam cells.
Kritharides L, Kus M, Brown AJ, Jessup W, Dean RT. Kritharides L, et al. J Biol Chem. 1996 Nov 1;271(44):27450-5. doi: 10.1074/jbc.271.44.27450. J Biol Chem. 1996. PMID: 8910326 - Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles. Particles containing various proportions of apolipoproteins A-I and A-II.
Lagrost L, Dengremont C, Athias A, de Geitere C, Fruchart JC, Lallemant C, Gambert P, Castro G. Lagrost L, et al. J Biol Chem. 1995 Jun 2;270(22):13004-9. doi: 10.1074/jbc.270.22.13004. J Biol Chem. 1995. PMID: 7768892 - Cyclodextrins: Potential therapeutics against atherosclerosis.
Mahjoubin-Tehran M, Kovanen PT, Xu S, Jamialahmadi T, Sahebkar A. Mahjoubin-Tehran M, et al. Pharmacol Ther. 2020 Oct;214:107620. doi: 10.1016/j.pharmthera.2020.107620. Epub 2020 Jun 26. Pharmacol Ther. 2020. PMID: 32599008 Review. - Cyclodextrins as therapeutic drugs for treating lipid metabolism disorders.
Wu J, Li J, Shao W, Hu Y, Chen H, Chen Y, Chen Y, Liu Q, Ao M. Wu J, et al. Obes Rev. 2024 Apr;25(4):e13687. doi: 10.1111/obr.13687. Epub 2024 Jan 10. Obes Rev. 2024. PMID: 38204297 Review.
Cited by
- Molecular and functional evidence of HCN4 and caveolin-3 interaction during cardiomyocyte differentiation from human embryonic stem cells.
Bosman A, Sartiani L, Spinelli V, Del Lungo M, Stillitano F, Nosi D, Mugelli A, Cerbai E, Jaconi M. Bosman A, et al. Stem Cells Dev. 2013 Jun 1;22(11):1717-27. doi: 10.1089/scd.2012.0247. Epub 2013 Feb 27. Stem Cells Dev. 2013. PMID: 23311301 Free PMC article. - Effect of plasma membrane cholesterol depletion on glucose transport regulation in leukemia cells.
Caliceti C, Zambonin L, Prata C, Vieceli Dalla Sega F, Hakim G, Hrelia S, Fiorentini D. Caliceti C, et al. PLoS One. 2012;7(7):e41246. doi: 10.1371/journal.pone.0041246. Epub 2012 Jul 30. PLoS One. 2012. PMID: 22859971 Free PMC article. - Cholesterol Depletion from a Ceramide/Cholesterol Mixed Monolayer: A Brewster Angle Microscope Study.
Mandal P, Noutsi P, Chaieb S. Mandal P, et al. Sci Rep. 2016 Jun 1;6:26907. doi: 10.1038/srep26907. Sci Rep. 2016. PMID: 27245215 Free PMC article. - Evaluation of cellular uptake and intracellular trafficking as determining factors of gene expression for amino acid-substituted gemini surfactant-based DNA nanoparticles.
Singh J, Michel D, Chitanda JM, Verrall RE, Badea I. Singh J, et al. J Nanobiotechnology. 2012 Feb 1;10:7. doi: 10.1186/1477-3155-10-7. J Nanobiotechnology. 2012. PMID: 22296763 Free PMC article. - Partial inclusion complex assisted crosslinked β-cyclodextrin nanoparticles for improving therapeutic potential of docetaxel against breast cancer.
Jain S, Desai MR, Nallamothu B, Kuche K, Chaudhari D, Katiyar SS. Jain S, et al. Drug Deliv Transl Res. 2022 Mar;12(3):562-576. doi: 10.1007/s13346-021-00956-z. Epub 2021 Mar 27. Drug Deliv Transl Res. 2022. PMID: 33774776
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical